Interim results show that the Bioplastics division is continuing to gain momentum with important new contracts signed, particularly with US-based customers. Existing Group KPIs have been adjusted and extended and are effective through to 2023. If achieved they suggest that the Bioplastics division and the Group would become EBITDA positive by the end of the period. To fund increased spend in the division, the Group is proposing to raise approximately £1.1m (gross) which will be used to
24 Sep 2020
Strong growth in Bioplastics and £1.1m fund raise
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Strong growth in Bioplastics and £1.1m fund raise
Biome Technologies PLC (BIOM:LON) | 100 0 0.0% | Mkt Cap: 3.78m
- Published:
24 Sep 2020 -
Author:
Ian Jermin -
Pages:
12
Interim results show that the Bioplastics division is continuing to gain momentum with important new contracts signed, particularly with US-based customers. Existing Group KPIs have been adjusted and extended and are effective through to 2023. If achieved they suggest that the Bioplastics division and the Group would become EBITDA positive by the end of the period. To fund increased spend in the division, the Group is proposing to raise approximately £1.1m (gross) which will be used to